Pharmacological Effects of Protocatechuic Acid in Disease Models

Protocatechuic acid (PCA) is a naturally occurring phenolic compound abundant in fruits, vegetables and medicinal herbs. Biochemically, PCA exerts potent antioxidant activity by scavenging reactive oxygen species and upregulating endogenous defence systems. It also modulates key signalling cascades, including nuclear factor-κB and mitogen-activated protein kinase pathways, thereby attenuating inflammatory cytokine production. In oncological models, PCA induces apoptosis through mitochondrial depolarisation, pro-oxidant effects in tumour cells and cell-cycle arrest via p21 activation. Antimicrobial and antiviral activities have been demonstrated in both in vitro and in vivo settings, highlighting PCA’s ability to disrupt microbial membranes and suppress viral replication. Neuroprotective studies reveal mitigation of ischemic injury and promotion of neuronal survival through inhibition of excitotoxicity. Furthermore, emerging work on nanoparticle formulations has improved PCA’s bioavailability and targeted delivery, suggesting practical applications in drug development. Collectively, these findings position PCA as a multifaceted agent with global relevance to cancer therapy, inflammatory disorders, infectious diseases and neurodegeneration.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Pharmacological Effects of Protocatechuic Acid in Disease Models publication trend

The graph below shows the total number of articles in pharmacological effects of protocatechuic acid in disease models across all publications each year (not limited to Nature Index journals).

Technical terms

Mastitis: Inflammation of the mammary gland, often induced experimentally by bacterial endotoxin.

PXR (Pregnane X receptor): A nuclear receptor that governs expression of detoxification enzymes and transporters.

Nanoparticles: Submicron carriers formulated to improve drug solubility, stability and targeted delivery.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen, implicated in cellular oxidative damage.

Cytokines: Signalling proteins secreted by immune and other cells to orchestrate inflammatory and immune responses.

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells): A transcription factor central to regulating inflammation and cell survival.

References

1. Ethyl Protocatechuate Encapsulation in Solid Lipid Nanoparticles: Assessment of Pharmacotechnical Parameters and Preliminary In Vitro Evaluation for Colorectal Cancer Treatment. Pharmaceutics (2023).
2. Protocatechuic acid inhibits LPS‐induced mastitis in mice through activating the pregnane X receptor. Journal of Cellular and Molecular Medicine (2023).
3. Pharmacological Properties of Protocatechuic Acid and Its Potential Roles as Complementary Medicine. Evidence-based Complementary and Alternative Medicine (2015).
4. Protocatechuic Acid, a Simple Plant Secondary Metabolite, Induced Apoptosis by Promoting Oxidative Stress through HO-1 Downregulation and p21 Upregulation in Colon Cancer Cells. Biomolecules (2021).
5. Protocatechuic Acid, a Novel Active Substance against Avian Influenza Virus H9N2 Infection. PLOS ONE (2014).